Session: Injection Drug Users Poster Session II
4101.0: Tuesday, November 18, 2003: 12:30 PM-2:00 PM
Poster
Injection Drug Users Poster Session II
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Board 1A randomized trial of accelerated vs. standard hepatitis B virus immunization in young IDU in San Francisco, the UFO Study
Paula J Lum, MD MPH, Judy Hahn, PhD, Kimberly Page Shafer, PhD, Jennifer Evans, MS, Peter J Davidson, BA, Ellen Stein, MPH, Susan E. Fernyak, MD, MPH, Andrew R Moss, PhD
Board 2Alcohol use among hepatitis C virus antibody positive injection drug users in three US cities
Jennifer Vernon Campbell, MSPH, Holly Hagan, PhD, Mary Latka, PhD, Richard S Garfein, PhD, MPH, Elizabeth T. Golub, PhD, MPH, David L. Thomas, MD, MPH, Steffanie A. Strathdee, PhD
Board 3Associations between STIs and prevalent HIV infection among injection and non-injection young drug users
Susan G. Sherman, MPH, PhD, Sabrina Plitt, MPH, Marcella Sapun, Crystal Fuller, MPH, PhD, Steffanie Strathdee, PhD
Board 4Circumstances surrounding the first injection episode and association with future needle sharing among young injection drug users
Laura A. Novelli, Susan G. Sherman, MPH, PhD, Jennifer R Havens, MPH, Marcella Sapun, Crystal Fuller, MPH, PhD, Steffanie A. Strathdee, PhD
Board 5Crack injection in New York: Narrative accounts of recent injection events
Stephen E. Lankenau, PhD, Michael Clatts, PhD, Lloyd Goldsamt, PhD
Board 6HIV among new injecting drug users in New York City, 1990-2001: Divergence among race/ethnic groups
Don C. Des Jarlais, PhD, Theresa E. Perlis, PhD, Kaymar Arasteh, PhD, Holly Hagan, PhD, Carey Maslow, PhD, Judith Milliken, Naomi Braine, PhD, Alan Neaigus, PhD, Samuel R. Friedman, PhD
Board 7Impact of syringe type on HIV and HCV epidemics among injecting drug users
William A. Zule, DrPH, Wendee Wechsberg, PhD, Wendy K.K. Lam, PhD, Winnie Luseno
Board 8Non-injecting heroin users (NIHU) in Chicago: Initiation, continued use and attitudes toward drug injection
Dita A. Davis, Lawrence J. Ouellet, PhD
Board 9Who enters higher quality drug treatment: Injection drug users and differences in human capital and institutional affiliation
Lena M. Lundgren, PhD, Robert F. Schilling, PhD, Faith Ferguson, PhD, Karen A. Davis, MSW, MPH, Maryann Amodeo, PhD
Board 10Acceptability and utility of a syringe disposal device for active injection drug users (IDUs)
Francis A. Wolf, BA, Michelle McKenzie, MPH, Stephanie L Sanford-Colby, MPH, Rachel S. Weston, BA, Grace E Macalino, PhD, Josiah D. Rich, MD, MPH
Organized by:Alcohol, Tobacco, and Other Drugs

The 131st Annual Meeting (November 15-19, 2003) of APHA